MOB Lender Appetite Is Holding, but the Capital Stack Has Opinions
As we move through the middle of 2026, medical office building financing remains one of the more resilient pockets of commercial real estate capital markets. That resilience is not uniform, and capital sources are pricing with increasing precision based on asset positioning, tenant credit, and campus affiliation. If you are planning a MOB acquisition, recapitalization, or ground-up development, understanding where lender conviction is concentrated matters more right now than any macro rate thesis.
Life insurance companies have maintained meaningful allocation toward healthcare real estate, and MOB specifically continues to attract their attention at the senior loan level. Their preference skews toward stabilized assets with strong credit tenancy, long weighted average lease terms, and limited near-term rollover risk. Life companies are not chasing yield on speculative deals. They are underwriting the covenant of the tenant, the irreplaceability of the location, and the likelihood of lease renewal given the capital investment operators make in clinical buildouts. When those boxes are checked, life company execution can be compelling in terms of rate, term, and non-recourse structure.
Healthcare REITs operating as equity partners or preferred capital providers represent a different but complementary dynamic. Several have pulled back from direct lending postures over the past cycle but remain active as joint venture partners, particularly where the sponsor brings operational relationships with health systems. Their appetite has narrowed toward deals where the health system relationship is documented and durable, not transactional.
Hospital-Anchored, On-Campus, and Off-Campus: The Pricing Gradient Is Real
Capital markets are pricing MOB along a clear spectrum tied to campus affiliation, and the spread between tiers has widened over the past several quarters. Hospital-anchored assets, particularly those with a health system as a direct tenant or guarantor on a significant portion of the net rentable area, represent the top of the credit quality ladder. Lenders treat these with a disposition closer to investment-grade net lease underwriting. Loan-to-value tolerances are higher, spreads are tighter, and non-recourse execution is more accessible.
On-campus assets without a direct hospital anchor occupy the middle band. Proximity to the main campus creates an operational stickiness that lenders recognize, and occupancy history tends to support that thesis. The underwriting still requires scrutiny of individual tenant covenants and lease structures, but the locational advantage holds weight in committee conversations.
Off-campus MOB is where the pricing gradient becomes most consequential. Assets in suburban or community locations with physician group tenants and shorter lease terms require lenders to work harder on the credit story. Specialty debt funds and bridge lenders remain active here, but they are pricing the additional risk accordingly. Spreads in this segment are meaningfully wider than on-campus product, and recourse requirements or carve-out structures are more common at the full loan level.
Credit-Tenant Lease Dynamics Are Driving Underwriting Outcomes
The credit-tenant lease structure remains the most powerful tool a developer or owner can bring to a MOB financing conversation. When a health system entity is the direct obligor on a long-term net lease, the financing often begins to look less like a real estate credit and more like a corporate bond with real property as collateral. Life companies in particular have significant experience underwriting this structure, and their execution efficiency reflects that familiarity.
Where the credit story is thinner, whether physician group tenancies without system guarantees, or shorter term leases with multiple smaller users, lenders shift their focus to asset-level cash flow durability and replacement tenant demand. Markets with demonstrated physician practice density and limited competing supply tell a better story than isolated community locations regardless of current occupancy.
Lease term structure is under specific scrutiny right now. Lenders are sensitive to weighted average lease expiration profiles that create balloon rollover risk inside the loan term. If a meaningful portion of leases expire within two to three years of the anticipated maturity date, expect that to generate significant discussion. Structuring deals with staggered expirations and demonstrable renewal option exercise history will improve your capital markets positioning materially.
Actionable Takeaways for Developers Planning Ahead
If you are in predevelopment or early entitlement on a MOB project, the capital markets environment rewards preparation on several specific dimensions. First, lock in health system engagement as early as possible and structure any pre-leasing or letters of intent to reflect the corporate entity as the obligor rather than a subsidiary without consolidated credit. Second, design lease structures with lender underwriting in mind from the start, including triple-net economics, longer initial terms with renewal options, and tenant improvement allowances commensurate with demonstrated clinical investment. Third, know your campus positioning thesis and be able to articulate it clearly, because lenders will price to it whether you frame the narrative or not.
Life company and healthcare REIT capital is available for the right product, but it is selective. Deals that can tell a credible credit-tenant story with clear campus affiliation and well-structured leases are getting done on favorable terms. Everything else is competing for a narrower pool of capital at a meaningfully higher cost.
If you have a medical office project in predevelopment, entitlement, or early capitalization planning, the CLS CRE team works directly with the capital sources most active in this segment. Contact us through our Commercial hub to discuss how your deal is positioned and where the right capital match likely sits in today's market.
Trevor Damyan is a commercial mortgage broker at Commercial Lending Solutions with a background in structured finance at CBRE and Marcus and Millichap Capital Corporation. He specializes in bridge loans, construction financing, SBA programs, DSCR loans, and complex capital structures for investors and developers across all 50 states.
View full profile →